Evidence map›Paper›PMID 30304511›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.

Julia Mwesigwa, Jane Achan, Muna Affara, Miriam Wathuo, Archibald Worwui, Nuredin Ibrahim Mohammed, Fatoumatta Kanuteh, Aurelia Prom, Susan Dierickx, Gian Luca di Tanna and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Mass drug administration for malaria.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Pooled it
  3. Dihydroartemisinin-Piperaquine Chemoprevention and Malaria Incidence After Severe Flooding: Evaluation of a Pragmatic Intervention in Rural Uganda.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. When Is Mass Prophylaxis Cost-Effective for Epidemic Control? A Comparison of Decision Approaches.Medical decision making : an international journal of the Society for Medical Decision Making · 2022
    Article
  20. Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.International journal for parasitology. Drugs and drug resistance · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Julia MwesigwaMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Jane AchanMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Muna AffaraMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Miriam WathuoMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Archibald WorwuiMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Nuredin Ibrahim MohammedMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Fatoumatta KanutehMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Aurelia PromMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Susan DierickxCentre of Expertise on Gender, Diversity and Intersectionality, Brussels University, Belgium.
Gian Luca di TannaRisk Centre, Institut de Recerca en Economia Aplicada, Department of Econometrics, Statistics and Applied Economics, Universitat de Barcelona, Spain.
Davis NwakanmaMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Chris DrakeleyFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom.
Jean Pierre Van GeertruydenDepartment of Global Health, Faculty of Medicine and Health Sciences, University of Antwerp.
Umberto D'AlessandroMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul.
MRC Unit the Gambia · GMLondon School of Hygiene & Tropical Medicine · GBGhent University · BERadboud University Nijmegen · NLUniversitat de Barcelona · ESUniversity of Antwerp · BE

Funding

Medical Research Council MC_EX_MR/J002364/1
6 · The paper itself

Abstract

backgroundMass drug administration (MDA) may further reduce malaria transmission in low-transmission areas. The impact of MDA on the dynamics of malaria transmission was determined in a prospective cohort study.

methodsAnnual rounds of MDA with dihydroartemisinin-piperaquine (DP) were implemented were implemented in 2014 and 2015 in six village pairs before the malaria transmission season. Blood samples were collected from residents between July and December for microscopy and nested PCR. Incidence and prevalence of infection, clinical disease, and risk of malaria reinfection post-MDA were determined.

resultsCoverage of three DP doses was 68.2% (2014) and 65.6% (2015), compliance was greater than 80%. Incidence of infection was significantly lower in 2014 (incidence rate [IR] = 0.2 per person year [PPY]) than in 2013 (IR = 1.1 PPY; P < .01); monthly infection prevalence declined in the first three months post-MDA. Clinical malaria incidence was lower in 2014 (IR = 0.1 PPY) and 2015 (IR = 0.2 PPY) than in 2013 (IR = 0.4 PPY; P < .01), but remained higher in eastern Gambia. Individuals infected before MDA had a 2-fold higher odds of reinfection post-MDA (adjusted odds ratio = 2.5, 95% confidence interval 1.5-4.3; P < .01).

conclusionsMDA reduced malaria infection and clinical disease during the first months. The reduction was maintained in low-transmission areas, but not in eastern Gambia. Annual MDA could be followed by focal MDA targeting individuals infected during the dry season. Repeated MDA rounds, some during the dry season over larger geographical areas, may result in a more marked and sustained decrease of malaria transmission.

Indexed as

Disease Transmission, InfectiousMass Drug AdministrationAdolescentAdultAgedAntimalarialsArtemisininsChildChild, PreschoolFemaleGambiaHealth Services ResearchHumansIncidenceInfantMalariaAntimalarialsArtemisininsartenimolpiperaquinePiperazinesQuinolinesclinical malariadihydroartemisinin-piperaquinegametocytesmalaria infectionmass drug administration

Identifiers

PMID30304511
PMCPMC6603267
OpenAlexW2897762870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.